Clinical Trial

Trial Protocol ID USOR 23066_TAS-120-205 *STAR*

Trial Description

Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Taiho Oncology, Inc.

ClinicalTrials.gov NCT ID

  • NCT05727176